
DVAX
Dynavax Technologies Corporation
$9.69
$0.00(0.00%)
54
Overall
--
Value
54
Tech
--
Quality
Market Cap
$1.14B
Volume
1.09M
52W Range
$9.20 - $14.63
Target Price
$22.67
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $4.0M | $11.0M | $327.0K | $8.2M | $37.8M | $54.3M | $447.2M | $730.4M | $239.9M | $282.3M | ||
Total Revenue | $4.0M | $11.0M | $327.0K | $8.2M | $35.2M | $46.6M | $439.4M | $722.7M | $232.3M | $277.2M | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | -- | -- | -- | $-10.9M | $19.4M | $13.9M | $173.6M | $262.2M | $50.2M | $49.4M | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $4.0M | $11.0M | $327.0K | $8.2M | $15.8M | $32.6M | $265.9M | $460.5M | $182.1M | $227.8M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $-109.1M | $-121.8M | $-96.3M | $161.5M | $137.3M | $107.9M | $132.4M | $178.0M | $207.8M | $231.9M | ||
Research & Development | $86.9M | $84.5M | $65.0M | $75.0M | $62.3M | $28.6M | $32.2M | $46.6M | $54.9M | $61.5M | ||
Research Expense | $86.9M | $84.5M | $65.0M | $75.0M | $62.3M | $28.6M | $32.2M | $46.6M | $54.9M | $61.5M | ||
Selling, General & Administrative | $22.2M | $37.3M | $27.4M | $75.7M | $75.0M | $79.3M | $100.2M | $131.4M | $152.9M | $170.4M | ||
Selling & Marketing Expenses | -- | $37.3M | $27.4M | $75.7M | -- | -- | -- | -- | -- | -- | ||
General & Administrative Expenses | $22.2M | $-2.2M | $-2.4M | $-4.0M | $75.0M | $79.3M | $100.2M | $131.4M | $152.9M | $170.4M | ||
Salaries & Wages | $-9.3M | $-14.1M | $-14.9M | $-23.5M | $25.5M | $13.5M | $21.3M | -- | -- | -- | ||
Depreciation & Amortization | $-1.4M | $-2.3M | $1.2M | $10.9M | $8.9M | $4.3M | $4.3M | $3.8M | $4.3M | $4.6M | ||
Depreciation & Amortization | $-1.4M | $-2.3M | $1.2M | $10.9M | $8.9M | $4.3M | $4.3M | -- | -- | -- | ||
Amortization | -- | -- | $1.2M | $10.9M | $11.7M | $2.5M | -- | $1.1M | $1.1M | $1.2M | ||
Other Operating Expenses | -- | -- | -- | -- | $6.9M | $6.3M | $-308.0K | -- | -- | -- | ||
OPERATING INCOME | ||||||||||||
Operating income | $-105.1M | $-110.7M | $-93.2M | $-153.3M | $-134.8M | $-68.4M | $134.5M | $283.5M | $-37.0M | $-4.1M | ||
EBITDA | $-104.2M | $-110.0M | $-90.9M | $-136.7M | $-115.6M | $-46.8M | $95.8M | $307.7M | $9.6M | $45.7M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | $572.0K | -- | -- | $9.3M | $17.0M | $19.1M | $11.2M | $6.7M | $6.8M | $6.8M | ||
Intinc | $205.0K | $755.0K | $1.3M | $3.8M | $3.4M | $1.3M | $140.0K | $7.9M | $32.0M | $36.5M | ||
Net Non-Operating Interest Income/Expense | $-367.0K | $755.0K | $1.3M | $-5.5M | $-13.6M | $-17.8M | $-11.0M | $1.2M | $25.2M | $29.7M | ||
Gain on Sale of Securities | $-500.0K | $-300.0K | -- | -- | -- | $100.0K | -- | -- | -- | -- | ||
Other Income/Expense | $1.4M | $2.5M | $486.0K | $70.0K | $6.8M | $-10.1M | $52.7M | $10.6M | $-848.0K | $-293.0K | ||
Other Special Charges | $-1.4M | $-2.5M | $-486.0K | $-70.0K | $-6.8M | $3.2M | $-53.7M | $1.9M | $-152.0K | $293.0K | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | -- | -- | $2.8M | -- | $13.4M | -- | -- | -- | -- | -- | ||
Special Income Charges | -- | -- | $-2.8M | -- | $-13.4M | -- | -- | -- | -- | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $-106.2M | $-112.4M | $-95.2M | $-149.6M | $-135.6M | $-56.2M | $88.7M | $301.0M | $2.4M | $37.6M | ||
Pre-Tax Income | $-106.8M | $-112.4M | $-95.2M | $-158.9M | $-152.6M | $-75.2M | $77.5M | $294.3M | $-4.4M | $30.9M | ||
INCOME TAX | ||||||||||||
Tax Provision | $-1.1M | $-700.0K | $-86.9M | $-53.0K | $-3.2M | $-3.2M | $808.0K | $1.1M | $2.0M | $3.5M | ||
NET INCOME | ||||||||||||
Net Income | $-106.8M | $-112.4M | $-95.2M | $-158.9M | $-152.6M | $-75.2M | $76.7M | $293.2M | $-6.4M | $27.3M | ||
Net Income (Continuing Operations) | $-106.8M | $-112.4M | $-95.2M | $-158.9M | $-152.6M | $-75.2M | $76.7M | $293.2M | $-6.4M | $27.3M | ||
Net Income (Discontinued Operations) | $-106.8M | $-112.4M | $-95.2M | $-158.9M | $-152.6M | $-75.2M | $76.7M | $293.2M | $-6.4M | $27.3M | ||
Net Income (Common Stockholders) | $-106.8M | $-112.4M | $-95.2M | $-158.9M | $-155.9M | $-75.2M | $72.1M | $292.9M | $-6.4M | $27.3M | ||
TOTALS | ||||||||||||
Total Expenses | $-109.1M | $-121.8M | $96.3M | $161.5M | $156.7M | $119.3M | $306.0M | $440.2M | $258.0M | $281.4M | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $32.9M | $38.5M | $52.6M | $62.4M | $72.0M | $100.8M | $116.3M | $126.4M | $128.7M | $130.0M | ||
Average Shares Outstanding (Diluted) | $32.9M | $38.5M | $52.6M | $62.3M | -- | $101.5M | $133.0M | $150.8M | $128.7M | $133.3M | ||
Shares Outstanding | $38.5M | $44.4M | $61.7M | $64.0M | $86.2M | $113.3M | $124.9M | $127.7M | $130.6M | $124.1M | ||
Basic EPS | -- | -- | -- | -- | $-2.16 | $-0.75 | $0.62 | $2.32 | $-0.05 | $0.21 | ||
Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-2.16 | $-0.75 | $0.62 | $2.32 | $-0.05 | $0.21 | ||
Diluted EPS | $-3.25 | $-2.92 | $-1.81 | $-2.55 | $-2.16 | $-0.78 | $0.57 | $1.97 | $-0.05 | $0.20 | ||
Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-0.78 | $0.57 | $1.97 | $-0.05 | $0.20 | ||
OTHER METRICS | ||||||||||||
Accrued Preferred Stock Dividends | -- | -- | -- | -- | $3.3M | -- | $4.6M | -- | -- | -- | ||
Commission Expenses | -- | -- | -- | $10.9M | -- | -- | -- | -- | -- | -- | ||
Fees | -- | -- | -- | -- | -- | $-2.5M | -- | -- | -- | -- | ||
Gain On Sale Of P P E | -- | -- | -- | -- | -- | $6.9M | $1.0M | $1.0M | $1.0M | -- | ||
Interest Expense Operating | -- | -- | -- | -- | -- | -- | $3.6M | -- | -- | -- | ||
Loss And Loss Adjustment Expected Incurred | -- | -- | -- | -- | $9.2M | -- | -- | -- | -- | -- | ||
Other Gand A | $22.2M | $-2.2M | $-2.4M | $-4.0M | $75.0M | $79.3M | $100.2M | $131.4M | $152.9M | $170.4M | ||
Otherunder Preferred Stock Dividend | -- | -- | -- | -- | $3.3M | -- | $4.6M | -- | -- | -- | ||
Preferred Stock Dividends | -- | -- | -- | -- | $3.3M | -- | $4.6M | -- | -- | -- | ||
Rent And Landing Fees | $22.2M | $-2.2M | $-2.4M | $-4.0M | -- | -- | -- | -- | -- | -- | ||
Selling Expense | -- | $37.3M | $27.4M | $64.8M | -- | -- | -- | -- | -- | -- | ||
Restruct | -- | -- | $2.8M | -- | $13.4M | -- | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | DVAX | $9.69 | 0% | 1.09M |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Dynavax Technologies Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW